Zanubrutinib (Brukinsa), a second-generation Bruton tyrosine kinase (BTK) inhibitor, has shown a tremendously elevated extend in disease development vs the regular of care ibrutinib (Imbruvica)…
Zanubrutinib (Brukinsa), a second-generation Bruton tyrosine kinase (BTK) inhibitor, has shown a tremendously elevated extend in disease development vs the regular of care ibrutinib (Imbruvica)…